The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
New Horizons in the Treatment of Osteosarcoma
Abstract
Osteosarcoma, which is most common in people 10 to 30 years of age, is generally treated with resection and adjuvant chemotherapy. Detection of gene rearrangements, copy-number variations, and targeted disruption of tumor suppressors by whole-genome sequencing has not yet led to improved treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many patients later diagnosed with osteosarcoma first seek medical care with concerns for persisting pain in an extremity 101 .”
From Osteosarcoma (2022) · cites this paper as [101]
Citations
Cites
1 retracted
RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
Feng, W., Dean, D. C., Hornicek, F. J., Spentzos, D., Hoffman, R. M., Shi, H., & Duan, Z. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920922055 · Cited by 57
RetractedNew Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21388 · Cited by 6,531
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
A System for the Surgical Staging of Musculoskeletal Sarcoma
Enneking, W. F., Spanier, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,661
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Bielack, S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.776 · Cited by 2,391
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Cited by
Sorted by citations
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 428
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Shi, P., Cheng, Z., Zhao, K., Chen, Y., Zhang, A., Gan, W., & Zhang, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01826-1 · Cited by 216
Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1471 · Cited by 95
A tumor microenvironment-based prognostic index for osteosarcoma
Wu, C., Gong, S., Duan, Y., Deng, C., Kallendrusch, S., Berninghausen, L. K., Osterhoff, G., & Schopow, N. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00917-3 · Cited by 94
Guan, Y., Zhang, W., Mao, Y., & Li, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02161-1 · Cited by 89
Origin and Therapies of Osteosarcoma
Moukengué, B., Lallier, M., Marchandet, L., Baud’huin, M., Verrecchia, F., Ory, B., & Lamoureux, F. (2022) · Cancers · doi:10.3390/cancers14143503 · Cited by 93
Current Status and Prospects of Clinical Treatment of Osteosarcoma
Jiang, Z.-Y., Liu, J., Wang, X., Ma, Y., & Fu, D. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221124696 · Cited by 79
Layered Double Hydroxides: A Novel Promising 2D Nanomaterial for Bone Diseases Treatment
Bian, Y., Cai, X., Lv, Z., Xu, Y., Wang, H., Tan, C., Liang, R., & Weng, X. (2023) · Advanced Science · doi:10.1002/advs.202301806 · Cited by 75
Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases
Han, J., Luo, J., Wang, C., Капилевич, Л. В., & Zhang, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116570 · Cited by 79
Current Status and Prospects of Targeted Therapy for Osteosarcoma
Hu, Z., Wen, S., Huo, Z., Wang, Q., Zhao, J., Wang, Z., Chen, Y., Zhang, L., Zhou, F., Guo, Z., et al. (2022) · Cells · doi:10.3390/cells11213507 · Cited by 78
Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors
Xie, M., Gong, T., Wang, Y., Li, Z., Lu, M., Luo, Y. W., Min, L., Tu, C., Zhang, X., Zeng, Q., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084139 · Cited by 73
Li, T., Gao, M., Wu, Z., Yang, J., Mo, B., Yu, S., Gong, X., Liu, J., Wang, W., Luo, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202206779 · Cited by 74
Chen, W., Li, Z., Yu, N., Zhang, L., Li, H., Chen, Y., Gong, F., Lin, W., He, X., Wang, S., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02129-1 · Cited by 71
Wang, Z., Zhai, B., Sun, J., Zhang, X., Zou, J., Shi, Y., & Guo, D. (2024) · Drug Delivery · doi:10.1080/10717544.2024.2400476 · Cited by 67
Chu, X., Zhang, L., Li, Y., He, Y. H., Zhang, Y. X., & Du, C. (2022) · Small · doi:10.1002/smll.202205414 · Cited by 60
What is the role of microbial biotechnology and genetic engineering in medicine?
Santos‐Beneit, F. (2024) · MicrobiologyOpen · doi:10.1002/mbo3.1406 · Cited by 60
Deep learning models in classifying primary bone tumors and bone infections based on radiographs
Wang, H., He, Y., Wan, L., Li, C., Li, Z., Li, Z., Xu, H., & Tu, C. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00855-3 · Cited by 65
Liu, Y., Jiang, Z., Tong, S., Sun, Y., Zhang, Y., Zhang, J., Zhao, D., Su, Y., Ding, J., & Chen, X. (2022) · Advanced Materials · doi:10.1002/adma.202203291 · Cited by 59
Surgical Treatment of Bone Sarcoma
Bläsius, F., Delbrück, H., Hildebrand, F., & Hofmann, U. K. (2022) · Cancers · doi:10.3390/cancers14112694 · Cited by 58
Ma, L., Zhou, J., Wu, Q., Luo, G., Zhao, M., Zhong, G., Zheng, Y., Meng, X., Cheng, S., & Zhang, Y. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122236 · Cited by 58
Wang, S., Chen, C., Wang, J., Li, C., Zhou, J., Liu, Y., Jiang, Y., Zhu, L., Li, C., Gong, W., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202208128 · Cited by 57
Chu, X., Mi, B., Xiong, Y., Wang, R., Liu, T., Hu, L., Yan, C., Zeng, R., Lin, J., Fu, H., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122714 · Cited by 56
Yu, K., Zhou, H., Xu, Y., Cao, Y., Zheng, Y., & Liang, B. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01955-7 · Cited by 54
The biomedical applications of nanozymes in orthopaedics based on regulating reactive oxygen species
Gao, X., Zhang, J., Gong, Y., & Yan, L. W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02844-3 · Cited by 56
Xiao, C., Fan, L., Zhou, S., Kang, X., Guan, P., Fu, R., Li, C., Ren, J. M., Wang, Z., Yu, P., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c07900 · Cited by 49
Du, J., Meng, X., Yang, M., Chen, G., Li, J., Zhu, Z., Wu, X., Hu, W., Tian, M., Li, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202410918 · Cited by 48
Yu, L., Zhu, H., Wang, Z., Huang, J., Zhu, Y., Fan, G., Wang, Y., Chen, X., & Zhou, G. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01624-7 · Cited by 49
Mannheimer, J., Tawa, G. J., Gerhold, D. L., Braisted, J. C., Sayers, C. M., McEachron, T. A., Meltzer, P. S., Mazcko, C. N., Beck, J. A., & LeBlanc, A. K. (2023) · Communications Biology · doi:10.1038/s42003-023-05208-z · Cited by 52
Self-citationWang, Y., Zhou, X., Li, Y., Hu, Q., Liu, H., Zhao, G., Wang, K., Zeng, J., Sun, M., & Lv, C. (2024) · Small · doi:10.1002/smll.202306916 · Cited by 46
Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0873 · Cited by 47
Zhang, G., Lu, Y., Song, J., An, M., An, M., Chen, W., Han, P., Yao, X., & Zhang, X. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.08.176 · Cited by 43
Vaishampayan, P., & Lee, Y. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103288 · Cited by 43
Sun, N., Lei, Q., Wu, M., Gao, S., Yang, Z., Lv, X., Wei, R., Yan, F., & Cai, L. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101053 · Cited by 40
PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT
Zhang, W., Li, W., Yin, C., Feng, C., Liu, B., Xu, H., Jin, X., Tu, C., & Li, Z. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0163 · Cited by 39
Yan, Z., Wu, X., Tan, W., Yan, J., Zhou, J., Chen, S., Miao, J., Cheng, J., Shuai, C., & Deng, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304595 · Cited by 39
Current status and future challenges of CAR-T cell therapy for osteosarcoma
Li, S., Zhang, H., & Shang, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290762 · Cited by 37
Wang, Y., Zhang, H., Qiang, H., Li, M., Cai, Y., Zhou, X., Xu, Y., Yan, Z., Dong, J., Gao, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304060 · Cited by 36
Zhang, F., Hao, Y., Yang, N., Liu, M., Luo, Y., Zhang, Y., Zhou, J., Liu, H., & Li, J. (2024) · BMC Cancer · doi:10.1186/s12885-024-11951-1 · Cited by 34
Patkar, S., Mannheimer, J., Harmon, S. A., Ramirez, C. J., Mazcko, C. N., Choyke, P. L., Brown, G. T., Türkbey, B., LeBlanc, A. K., & Beck, J. A. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1854 · Cited by 35
Immunosuppressive Tumor Microenvironment of Osteosarcoma
Taylor, A. M., Sheng, J., Ng, P. K. S., Harder, J. M., Kumar, P., Ahn, J. Y., Cao, Y., Dzis, A. M., Jillette, N., Goodspeed, A. E., et al. (2025) · Cancers · doi:10.3390/cancers17132117 · Cited by 38
Cheng, D., Zhang, Z., Mi, Z., Tao, W., Liu, D., Fu, J., & Fan, H. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107417 · Cited by 32
Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis
Zou, Y., Guo, S., Wen, L., Lv, D., Tu, J., Liao, Y., Chen, W., Chen, Z., Li, H., Chen, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101728 · Cited by 32
Nanomaterial-assisted theranosis of bone diseases
Zheng, K., Bai, J., Yang, H., Xu, Y., Pan, G., Wang, H., & Geng, D. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.12.014 · Cited by 32
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
Kinnaman, M. D., Zaccaria, S., Makohon-Moore, A. P., Arnold, B., Levine, M. F., Gundem, G., Ossa, J. A., Głodzik, D., Rodriguez-Sanchez, I., Bouvier, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0385 · Cited by 31
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan, P., Wang, J., Yue, B., & Wang, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189171 · Cited by 31
Yan, Z., Deng, Y., Huang, L., Zeng, J., Wang, D., Tong, Z., Fan, Q., Tan, W., Yan, J., Zang, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03253-w · Cited by 31
Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
Du, X., Wei, H., Zhang, B., Wang, B., Li, Z., Pang, L. K., Zhao, R., & Yao, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1117867 · Cited by 31
Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy
He, L., Habibović, P., & van Rijt, S. (2023) · Biomaterials Science · doi:10.1039/d2bm02102a · Cited by 30
van Ewijk, R., Herold, N., Baecklund, F., Baumhoer, D., Boye, K., Gaspar, N., Harrabi, S., Haveman, L., Hecker‐Nolting, S., Hiemcke‐Jiwa, L. S., et al. (2023) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2023.100029 · Cited by 33
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma
An, F., Chang, W., Song, J., Zhang, J., Li, Z., Gao, P., Wang, Y., Xiao, Z., & Yan, C. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100521 · Cited by 30
Du, T., Liu, J. S., Dong, J., Xie, H., Wang, X., Yang, X., & Yang, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1325707 · Cited by 30
Huang, X., Xia, K., Wei, Z., Liu, W., Wei, Z., & Guo, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05803-6 · Cited by 31
White, L. M., Atinga, A., Naraghi, A., Lajkosz, K., Wunder, J. S., Ferguson, P. C., Tsoi, K. M., Griffin, A. M., & Haider, M. A. (2022) · Skeletal Radiology · doi:10.1007/s00256-022-04098-2 · Cited by 30
A Review of Advanced Biomaterials and Cells for the Production of Bone Organoid
Li, C., Zhang, Y., Du, Y., Hou, Z., Zhang, Y., Cui, W., & Chen, W. (2023) · Small Science · doi:10.1002/smsc.202300027 · Cited by 30
Multifunctional 3D-printed bioceramic scaffolds: Recent strategies for osteosarcoma treatment
Liu, X., Liu, Y., Qiang, L., Ya, R., Lin, Y., Li, H., Chen, Q., Gao, S., Yang, X., Zhang, C., et al. (2023) · Journal of Tissue Engineering · doi:10.1177/20417314231170371 · Cited by 30
Yu, L., Fan, G., Wang, Q., Zhu, Y., Zhu, H., Chang, J., Wang, Z., Zhan, S., Hua, X., She, D., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06159-3 · Cited by 28
Kushram, P., Majumdar, U., & Bose, S. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213667 · Cited by 28
Gu, H.-Y., Fan, J., Bao, P., Qu, W., Hu, Z., Qi, B., Zhang, X., & Yu, A. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202311015 · Cited by 27
Construction of Osteosarcoma Diagnosis Model by Random Forest and Artificial Neural Network
Li, S., Que, Y., Yang, R., He, P., Xu, S., & Hu, Y. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030447 · Cited by 26
Zeng, X., Liu, S., Yang, H., Jia, M., Liu, W., & Zhu, W. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad070 · Cited by 26
Zhang, X., Zhao, Z., Wang, X., Zhang, S., Zhao, Z., Feng, W., Xu, L., Nie, J., Li, H., Liu, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06727-1 · Cited by 28
Li, R., Liu, K., Hu, Q., Shen, J., Zuo, D., Wang, H., Zhu, X., & Sun, W. (2024) · Aggregate · doi:10.1002/agt2.658 · Cited by 26
Research progress on the molecular mechanisms of Saikosaponin D in various diseases (Review)
Gu, S., Zheng, Y., Chen, C., Liu, J., Wang, Y., Wang, J., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5478 · Cited by 27
Xie, D., Hu, C., Zhu, Y., Yao, J., Li, J., Xia, J., Ye, L., Jin, Y., Jiang, S., Hu, T., et al. (2024) · Small · doi:10.1002/smll.202406639 · Cited by 27
Fan, D., Zhang, C., Wang, H., Wei, Q., Cai, H., Wei, F., Bian, Z., Liu, W., Wang, X., & Liu, Z. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100683 · Cited by 26
Xu, Y., Yang, L., Li, M., Shu, H., Jia, N., Gao, Y., Shi, R., Yang, X., Zhang, Z., & Zhang, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.10.005 · Cited by 26
Liu, Y., Dong, S., Hu, W., Chen, Q., Zhang, S.-F., Song, K., Han, Z.-C., Li, M., Han, Z., Liu, W., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.02.007 · Cited by 25
PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma
Liu, B., Li, W., Zhang, W., Feng, C., Wan, L., He, S., Xu, R., Fu, Z., Liu, Z., Xu, H., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02250-7 · Cited by 25
Wang, Z., Fan, G., Zhu, H., Yu, L., She, D., Wei, Y., Huang, J., Li, T., Zhan, S., Zhou, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980390 · Cited by 25
The roles and mechanisms of circular RNAs related to mTOR in cancers
Cao, C., Wang, Y., Wu, X., Li, Z., Guo, J., & Sun, W. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24783 · Cited by 26
Zeng, J., Peng, Y., Wang, D., Ayesha, K., & Chen, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1123065 · Cited by 31
Cheng, L., Xiong, W., Li, S., Wang, G., Zhou, J., & Li, H. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3563 · Cited by 24
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma
Wang, C., Zhang, Y., Kong, W., Rong, X., Zhong, Z., Jiang, L., Chen, S., Li, C., Zhang, F., & Jiang, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s471900 · Cited by 25
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Robinson, M. J., & Davis, E. J. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01269-2 · Cited by 27
Towards precision medicine: design considerations for nanozymes in tumor treatment
Li, X., Hu, J., Zhao, Q., Yao, W., Jing, Z., & Jin, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05845-w · Cited by 24
CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
Cheng, J., Zhang, Y., Wan, R., Zhou, J., Wu, X., Fan, Q., He, J., Tan, W., & Deng, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.919108 · Cited by 24
P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization
Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H. K., & Yang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03985-z · Cited by 24
Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
Tan, L., Wang, Y., Hu, X., Du, G., Tang, X., & Min, L. (2023) · Biomolecules · doi:10.3390/biom13091362 · Cited by 24
Hui, T., Fu, J., Zheng, B., Fu, C., Zhao, B., Zhang, T., Zhang, Y., Wang, C., Yu, L., Yang, Y., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c10572 · Cited by 24
Deng, X., Zhao, R., Tang, Y., Yi, M., Ge, Z., Wang, D., Fang, Q., Xiong, Z., Duan, A., Liu, W., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11749 · Cited by 24
Biomaterials‐Boosted Immunotherapy for Osteosarcoma
Sun, C., Li, S., & Ding, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400864 · Cited by 25
Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy
Yu, Y., Li, K., Peng, Y., Zhang, Z., Pu, F., Shao, Z., & Wu, W. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101569 · Cited by 26
Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies
Han, Z., Chen, G., & Wang, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1579822 · Cited by 25
Bielack, S., Blattmann, C., Borkhardt, A., Csóka, M., Hassenpflug, W. A., Kabíčková, E., Kager, L., Kessler, T., Kratz, C. P., Kühne, T., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.007 · Cited by 23
Ji, H., Kong, L., Wang, Y., Hou, Z., Kong, W., Qi, J., & Jin, Y. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100487 · Cited by 23
Zhang, D., Xu, R., Chen, S., Du, H., Shi, Q., Peng, F., & Liu, X. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.07.012 · Cited by 23
Silver, K. I., Patkar, S., Mazcko, C. N., Berger, E. P., Beck, J. A., & LeBlanc, A. K. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12927 · Cited by 22
Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases
Zhou, R., Hu, W., Ma, P. X., & Liu, C.-J. (2024) · Bone Research · doi:10.1038/s41413-024-00370-4 · Cited by 22
Li, Q., Wei, W., Wang, K., Shi, X., Ling, G., & Zhang, P. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110777 · Cited by 22
Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights
Zhang, Y., Jiang, S., Lv, J., Feng, W., Yu, Y., & Zhao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584450 · Cited by 22
Zhang, D., Liu, H., Wang, W., Xu, G., Yin, C., & Wang, S. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2136465 · Cited by 22
Tan, J., Yang, B., Zhong, H., Luo, M., Su, Z., Xie, C. L., Shi, M., Sun, C., & Lin, L. (2023) · Biomarker Research · doi:10.1186/s40364-022-00442-9 · Cited by 22
Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma
Zhong, L., Wang, J., Chen, W., Lv, D., Zhang, R., Wang, X., Zeng, C., He, X., Zheng, L., Gao, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi0889 · Cited by 22
Zeng, F., Li, C., Wang, H., Wang, Y., Ren, T., He, F., Jiang, J., Xu, J., Wang, B., Wu, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202310167 · Cited by 23
Li, F., Tang, H., Luo, X., Li, X., Luo, K., Liu, S., Liang, J., Liao, S., Zhong, C., Zhan, X., et al. (2023) · Cancer Science · doi:10.1111/cas.15821 · Cited by 22
Metal ions and nanomaterials for targeted bone cancer immunotherapy
Qin, S., Hu, Y., Luo, H., Chu, W., Deng, R., & Ma, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1513834 · Cited by 21
Biodegradable Carbon Dioxide‐Derived Non‐Viral Gene Vectors for Osteosarcoma Gene Therapy
Li, M., Lin, Z., Yang, J., Huang, H., Liu, G., Liu, Q., Zhang, X., Zhang, Y., Xu, Z., Lin, H., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201306 · Cited by 21
Chen, W., Lin, W., Yu, N., Zhang, L., Wu, Z., Chen, Y., Li, Z., Gong, F., Li, N., Chen, X., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s379917 · Cited by 21
Lv, Z., Wu, Y., Lin, J., Li, W., Weisbecker, H., Wang, P., Song, X., Sun, W. Y., Sun, Z., Xie, Y., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202312032 · Cited by 22
Metadata
- Authors
- Meltzer, P. S., & Helman, L. J.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Meltzer, Paul S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-11-25
- Volume
- 385
- Issue
- 22
- Pages
- 2066-2076
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3217429854
- Cited by
- 672
- References
- 67
- Citations by year
- 2026: 123 · 2025: 173 · 2024: 156 · 2023: 143 · 2022: 74
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- osteosarcoma, gene rearrangement, copy number variation, tumor suppressor, targeted therapy, whole genome sequencing, adjuvant chemotherapy, pediatric bone tumors
- MeSH terms
- Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms, Humans, Immunotherapy, Prognosis, Osteosarcoma, Survival Rate, Neoadjuvant Therapy, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review